BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24098650)

  • 1. Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis.
    Sadjadi A; Yazdanbod A; Lee YY; Boreiri M; Samadi F; Alizadeh BZ; Islami F; Fyfe V; Babaei M; Namazi MJ; Going JJ; Sotoudeh M; de Bock GH; Malekzadeh R; Derakhshan MH
    PLoS One; 2013; 8(9):e74440. PubMed ID: 24098650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort.
    Ren JS; Kamangar F; Qiao YL; Taylor PR; Liang H; Dawsey SM; Liu B; Fan JH; Abnet CC
    Gut; 2009 May; 58(5):636-42. PubMed ID: 19136509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer.
    Derakhshan MH; Malekzadeh R; Watabe H; Yazdanbod A; Fyfe V; Kazemi A; Rakhshani N; Didevar R; Sotoudeh M; Zolfeghari AA; McColl KE
    Gut; 2008 Mar; 57(3):298-305. PubMed ID: 17965056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
    Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas.
    Murphy G; Kamangar F; Dawsey SM; Stanczyk FZ; Weinstein SJ; Taylor PR; Virtamo J; Abnet CC; Albanes D; Freedman ND
    J Natl Cancer Inst; 2011 Jul; 103(14):1123-9. PubMed ID: 21693726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ghrelin and esophageal and gastric cancer in two cohorts in China.
    Pritchett NR; Maziarz M; Shu XO; Kamangar F; Dawsey SM; Fan JH; Ji BT; Gao YT; Xiang YB; Qiao YL; Li H; Yang G; Wang SM; Stanczyk FZ; Chow WH; Katki HA; Zheng W; Lan Q; Freedman ND; Rothman N; Abnet CC; Murphy G
    Int J Cancer; 2020 May; 146(10):2728-2735. PubMed ID: 31351006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach.
    Yu G; Gail MH; Shi J; Klepac-Ceraj V; Paster BJ; Dye BA; Wang GQ; Wei WQ; Fan JH; Qiao YL; Dawsey SM; Freedman ND; Abnet CC
    Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):735-41. PubMed ID: 24700175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum pepsinogens and risk of esophageal squamous dysplasia.
    Kamangar F; Diaw L; Wei WQ; Abnet CC; Wang GQ; Roth MJ; Liu B; Lu N; Giffen C; Qiao YL; Dawsey SM
    Int J Cancer; 2009 Jan; 124(2):456-60. PubMed ID: 18844222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
    Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
    Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
    Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study.
    Dong Z; Zhang X; Chen X; Zhang J
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31414587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma.
    Murphy G; Kamangar F; Albanes D; Stanczyk FZ; Weinstein SJ; Taylor PR; Virtamo J; Abnet CC; Dawsey SM; Freedman ND
    Gut; 2012 Nov; 61(11):1533-7. PubMed ID: 22180062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.